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ABSTRACT 
Ginger was reported to have a suppressive effect on pain in patients with Painful Diabetic 
Neuropathy (PDN). Our latest study revealed that 6-shogaol, one of the ginger components, had 
the best affinity in the Transient Receptor Potential Vanilloid 1 (TRPV1), a key receptor in PDN). 
Paradol, which obtained from gingerol and shogaol metabolism, also had potent activities in 
several diseases, compared to the other derivatives of gingerol and shogaol. However, shogaol and 
paradol is very similar in chemical structure with only different in one double bond in 4-5 position. 
Until now there is no explanation about paradol mechanism in TRPV1. Based on this, our study 
was designed to predict the activity of 6-paradol and its derivatives to TRPV1 as target receptor in 
PDN using in-silico model. 2-paradol, 4-paradol, 6-paradol, 8-paradol and 10-paradol were used as 
ligands. Capsaisin, the agonist of TRPV1, was used as a native ligand in this study. TRPV1 was 
obtained from protein data bank (PDB). Ligand bond prediction and affinity was performed using 
Molegro Virtual Docker. The results showed 2-paradol, 4-paradol, 6-paradol, 8-paradol and 10-
paradol had good affinity against TRPV1. These result indicated that 6-paradol and the derivatives 
had potential as a drug compound for PDN therapy. 
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INTRODUCTION 
Ginger is one of plants, which regulates central 
nervous system (CNS) disorder by modulating 
inflammatory pathways (Gaire et al., 2015). 
Previous report investigated that ginger juice 
had analgesic effect in hot plate-induced pain 
in rats (Mantiri et al, 2013). Main compound, 
which is believed responsible for this activity 
in ginger, were gingerol, shogaol and paradol 
(Black et al., 2010, Ali et al., 2008). Another 
finding, gingerol, shogaol, zingerone, 
diarylheptanoids and its derivatives especially 
paradol worked through cyclooxygenase 
inhibition and caused the decreasing of 
prostaglandin synthesis, then reduced pain 
(Black et al., 2010, Ali et al., 2008, Haghighi 
et al., 2005, Mantiri et al, 2013).  8-Paradol 
also known has an ability to inhibit platelet 
aggregation and potential as inhibitor of 
cyclooxygenase-1 agent (Nurtjahja-
Tjendraputra et al., 2003). 
Painful diabetic neuropathy (PDN) is a 
complex chronic disorder, related to 
abnormality of nervous system in patients with 
diabetic. Higher incidence in PDN is depends 
on aging and also duration of diabetes mellitus 
(Hutapea et al, 2016). Many agents are 
involved in pathophysiology of PDN such as 
glucose metabolism flux through the polyol 
pathway; the hexosamine pathway; excess or 
inappropriate activation of protein kinase C 
(PKC) isoforms; and accumulation of advanced 
glycation end products (AGEs)  (Smith & 
Argoff, 2013). It is important to treat PDN 
because its complex pathophysiology and 
impact into patient's quality of life. 
Non-steroidanti-inflammatory drugs 
(NSAIDs) and opioid analgesic were reported 
fail to overcome pain in PDN. The other agents 
such as antidepressant also did not effective 
and had a high side effect effect (Wahyuliati, 
2006). That's why it is challenging to find a 
new substance to treat PDN. One of the target 
drugs to treat PDN is the transient receptor 
protein vanilloid-1 (TRPV1). 
TRPV1 is a non-selective cation channel 
which is permeable to Ca2+. In our body, 
TRPV1 is expressed in peripheral sensory 
nerves and essential for certain modalities of 
pain sensation and for tissue injury-induce 
thermal hyperalgesia (Kano et al., 2009). 
Insulin deficiency causes down regulation of 
TRPV1 expression, which is related into 
hyperalgesia and hypoalgesia (Pabbidi et al., 
2008). TRPV1 can be blocked using its agonist 
via desensitization mechanism and antagonist 
receptor (Suri & Szallasi, 2008). 
Desensitization action via agonist significantly 
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decreasing the fasting plasma insulin levels, 
improving glucose tolerance via enhancement 
of insulin secretion and increased glucose 
infusion rate during due glycemic 
hyperinsulinemic clamp versus vehicle controls 
(Gram et al., 2005). Capsaicin, one of the 
compounds in plants, which had been already 
studied as agonist TRPV1 and used as PDN 
treatment. Capsaicin used in topical form for 
PDN patient because of the limitation 
according to side effect in gastrointestinal of 
capsaicin when it is used orally. Based on (Suri 
& Szallasi, 2008) capsaicin bound selectively 
and reversible to TRPV1. 
6-paradol, an TRPV1 agonist same as 
capsaicin, was found as minor component in 
ginger, but known more effective than 6-
shogaol from in vitro and in vivo study. 6-
paradol has been recognized as a bioactive 
species, and it has been investigated for various 
biological or pharmacological activities, such 
as neuroprotective effects, anti-obesity effects 
(Wei et al., 2017), tumor suppressing effects, 
chemopreventive properties (Keum et al., 
2002), antioxidant effects, and COX1 inhibitor 
(Nurtjahja-Tjendraputra et al., 2003). This 
compound was a metabolite from 6-shogaol 
which is come from reduction reaction (Jo et 
al., 2016, Wei et al., 2017). That's why 6-
paradol directly administration is suggested 
more effective and faster to treat PDN.  
There is no information regarding the 
activity of 6-paradol and another paradol 
derivates in TRPV1. So, our study was aimed 
to investigate and predict the binding of 6-
paradol and its derivates in TRPV1 using in-
silico method. This result is important to find 
new substances in PDN therapy with the same 
activity as capsaicin but give lower side effect 
as well. 
MATERIAL AND METHOD 
Software and hardware Molecular docking was analyzed using Notebook 
brand Asus E203NAH with processor Intel(R) 
Celeron(R) CPU N3350 @ 1.10GHz and Molegro 
Virtual Docker 2013.6.0.1 as the software for 
docking. TRPV1 protein and the native ligand 
(4DY) were extracted from Protein Data Bank 
(PDB) with code 2N27. The 2N27 was consisted 
byprotein structure, native ligand (4DY, capsaicin) 
and cofactors. The structure of 6-paradol and 
derivatives were created with ChemDraw 
Professional 15.1. then minimized the energy using 




The structures of Capsaicin, 6-paradol and its 
derivatives were drawn used ChemDraw 
Professional 15.1 to get 2D molecule structures. 
Optimization of the geometrical isomeric structure 
of all compounds were done by minimizing energy 
(MM2) using Chem3D 15.1 and then saved as Mol2. 
Cavity preparation 
Cavities were detected using software Molegro 
Virtual Docker by import 2N27.pdb file. Cavity was 
chosen based on the presence of native ligands 
attached to the cavity that had been formed. 
Validation 
Validation was determined by docking native 
ligands and capsaicin compounds to the selected 
cavity. There were 20 models of native ligand then 
was chosen based on who has the smallest RMSD. 
RMSDS showed the similarity or compatibility 
between the compound that was docked with the 
selected cavity. The native ligand (4DY) capsaicin 
was validated with three times replications. 
Molecular docking of 6-paradol and its 
derivatives 
PDB protein file and other compounds with Mol2 
format then were imported into Molegro Virtual 
Docker. The 6-paradol and its derivatives were 
docked with the general settings with three times 
validation. The result was shown as rerank score, 
root mean square deviation (RMSD) score, and also 
hydrogen bond. The affinity ability was described 
using rerank score which defined the energy to bind 
the protein or receptor as target. 
Hydrogen bonds 
Hydrogen bonds and steric interactions were 
obtained through the imported docking result using 
Molegro Virtual Docker 2013.6.0.1 as the software 
for docking. 
Physicochemical parameters 
The physicochemical parameters were taken from 
the ChemDraw Professional 15.1 software. We got 
the information about chemical properties such as 
log P and MR value using import two-dimension 
structure of each compound.  
Data Analysis 
All data are expressed as mean ± S.E.M. Data 
analysis was processed through IBM SPSS Statistics 
22 software using one-way-ANOVA test. Data were 
considered significant when p values ≤ 0.05.  
RESULTS AND DISCUSSION 
The docking method is used to determine the 
binding ability between the structure of the 6-
paradol and its derivatives with TRPV1 as the 
pain receptor target. In this research, we can 
not get RMSD value ≤2 after validating 
4TRPV1 code using PDB i.e. 2N27, 3J5R, 
5IRZ and 3J9J. The TRPV1 code 3J9J did not  
 
 
Jurnal ILMU DASAR, Vol. 21  No. 2, Juli 2020 : 133-138                                                      135  
 Journal homepage: https://jurnal.unej.ac.id/index.php/JID 
include native ligand and capsaicin as native 
ligand in code 5IRZ did not find inside the 
cavity, that's why both of them were excluded 
for further test. After validating, we found that 
the smallest RMSD was shown using TRPV1 
(2N27), with RMSD value 6.78792. Then, we 
chose this ligand to compare the affinity 
between 6 paradol and its derivates using 
capsaicin as native ligand. This result did not 
describe the ideal situation for validation, and 
this might be the limitation of our study. 
Our result showed capsaicin in cavity 1 that 
had the smallest RMSD then reanalyzed three 
times, as seen in Table 1. Hydrogen bonds 
were seen in Fig. 1. 







1 -1362.55 6.78792 -1835.49 
2 -1365.2 11.8887 -1790.89 
3 -1368.42 7.80868 -1928.16 
Molecular Docking analyzed using cavity 1 
as the best cavity which had been validated 
with native ligand. The docking of each 
compounds were tested in three replications. 
Docking was evaluated by positioning all 
compounds in the same place with the results 
of validation. Molecular docking results with 
Molegro Virtual Docker in the form of pose 
assessment functions such as DockSore, 
HBond, RMSD and Rerank Score 
(Puspaningtyas et al., 2012). Rerank score 
indicates the energy needed for a compound to 
bind to the receptor so that the smaller rerank 
score means that the energy needs to bind into 
the receptor is also smaller. The binding energy 
is related to the affinity value of ligand bonds 
with receptors (Fajrin et al., 2018). Affinity can 
be determined as tendency of a compound to 
form chemical bonds with other elements or 
compounds. Smaller rerank score means that it 
had the higher affinity. Based on one way 
ANOVA test, capsaicin has significantly 
different with 2-paradol, see at table 2. But 2-
paradol has the biggest rerank score value that 
means it has the lowest affinity to the TRPV1.  
The physicochemical parameter values used 
include lipophility properties in the form of 
partition coefficient (LogP) values and 
structural disabilities based on the molar 
refractivity values (MR) shown in the table 3. 
Lipophility is the ability of compounds to be 
able to pass through cell membranes, while the 
structural friction of the test compounds will 
increase the likelihood of good interactions on 
the target side of the active enzyme. The results 
show that 10-paradol has the highest logP 
value and 2-paradol has the smallest logP value 
where it wassimilar tendency with its MR 
value.Capsaicin as native ligand had a logP 
between 2-paradol and 4-paradol. 
Table 2. Molecular docking result of 6-paradol and its derivatives 
Ligand Rerank Score Mean ± SEM 1 2 3 
Capsaicin -1362.55 -1365.2 -1368.42 -1365.39± 1.69718a 
2-Paradol -1181.82 -1179.51 -1237.69 -1199.67 ± 19.02003b 
4-Paradol -1224.23 -1253.01 -1312.36 -1263.20± 25.94611ab 
6-Paradol -1379.42 -1315.43 -1301.45 -1332.10± 24,00171a 
8-Paradol -1279.9 -1393.96 -1313.68 -1329.18± 33.82607a 
10-Paradol -1336.02 -1268.97 -1254.1 -1295.98± 15.48327a 
Note: a is significantly different versus b 
Table 3. Physicochemical parameters 
Substance LogP MR 
Capsaicin 3.66 91.4 
2-Paradol 3.02 63.47 
4-Paradol 3.85 72.66 
6-Paradol 4.69 81.86 
8-Paradol 5.52 91.06 
10-Paradol 6.35 100.26 
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LogP value increased as the number of the 
carbon chain. Capsaicin has a logP value of 
3.66, 2-paradol has a logP value of 3.02 and 
10-paradol has the largest logP value of 6.35. 
High lipophility cause a higher the partition 
coefficient, but on the other side the higher log 
P value could reduce the activity 
(Puspaningtyas et al., 2012).  
The increasing of the carbon chain on 2-
paradol to 6-paradol can affect to decrease the 
rerank score and increase the lipophility and 
molar refraction. Otherwise, on 6-paradol to 
10-paradol the value of rerank score increase 
while the lipophility and the molar refraction 
have increase. It showed that the affinity of 8-
paradol and 10-paradol were lower than 6-
paradol. It may cause of the longer carbon 
chain induced the lipophility and the molar 
refraction. If a substance which was too 
lipophilic and had a big molar refraction would 
be difficult to pass through the membrane cell. 
Cell membranes in the body consist of 
hydrophilic and lipophilic compounds called 
phospholipid bilayers. If a compound is too 
hydrophilic or lipophilic, it will be difficult for 
the compound to enter the cell. Our result 
showed that 6-paradol had the lowest binding 
energy, and not significantly with capsaicin as 
native ligand. This compound also had 
lipophility value and molar refraction similar to 
capsaicin. 
Other information obtained was the number 
of carbon chains of 6-paradol and its 
derivatives. The increase in carbon chains 
affected their binding to receptor and could be 
seen through the change in hydrogen bonds and 
steric interactions. Based on previous research, 
hydroxyl (-OH) and -OCH3 groups have important functions for the agonist and TRPV1 
antagonist compounds (Su et al., 2011). 
Hydrogen bonds were a strong interaction 
between hydrogen, which it bound to the atom 
that had one pair electron with one of oxygen 
or nitrogen or fluorine. The hydrogen bond of 
capsaicin, 2-paradol, 4-paradol and 8-paradol 
were same with leucine and threonine, see at 
the table 4 and Fig. 2. Otherwise, the 6-paradol 
had different hydrogen bond, they were 
glutamine and glutamic acid. Different with the 
others, 10-paradol did not have any hydrogen 
bond to receptor. It might cause of the long 
chain of the structure affect the hydrogen bond. 
But it did not mean 10-paradol could not bind 
to the receptor, it bind to the receptor with 
another interaction. Another interaction that 
could be observed was steric interaction. 
 
Fig. 1. A. Cavity 1 position in TRPV1 protein 
(2N27) was shownas the green area,  
B. The binding site of capsaicin inthe 
cavity 1 
 
Fig. 2. Hydrogen bonds interaction of A. 
Capsaicin, B. 2-paradol, C. 4-paradol, 




Fig. 3. Hydrogen bonds interaction between 
amino acid and A. Capsaicin, B. 2-
paradol 
Table 4.  Hydrogen bonds between amino acid 
and the compound 







Capsaicin + + - - - 
2-Paradol + + - - - 
4-Paradol + + - - - 
6-Paradol - - + + + 
8-Paradol + + - - - 
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Table 5.  Hydrogen bonds Value 









Fig. 4. Steric interactions of A. Capsaicin, B. 2-
paradol, C. 4-paradol, D. 6-paradol, E. 
8-paradol and F. 10-paradol 
Steric interactions was related to the 
clustering properties of the group and the effect 
of the group compound that bind to the amino 
acid of the side protein receptor (Suhud, 2015). 
Steric interactions was related to structure and 
shape conformation of the compound,in this 
case was mainly observed the additional of the 
side chain. Docking compounds were 
compounds that already had been minimized 
the energy so that they were expected to be in 
the most stable conformational form. Steric 
interactions that occurred in all compounds had 
different amounts and amino acids and some 
were the same. As the result capsaicin had 
steric interaction with threonine, isoleucine, 
phenylalanine, methionine, leucine, valine, 
glutamic acid, and asparagine, as we can see in 
Fig. 3. 
When capsaicin is compared with 2-paradol 
and 4-paradol, it has the same number of steric 
interactions bondwith some amino acids, they 
are threonine, methionine, isoleucine, and 
leucine. Longer chain, especially in 6-paradol, 
8-paradol and 10-paradol can affect the number 
ofsteric interactions which was had additional 
steric interaction with threonine, isoleucine, 
phenylalanine, methionine, leucine, valine, 
glutamic acid, asparagine. 
The docking method is carried out in the 
same position with the native ligan position 
that has been validated before. However, the 
conformation structure ofeach compound is 
differences in the length chain, so it is possible 
to affect the flexible structure on the part of the 
chain and also affect to the results in different 
steric interactions with the receptors. Rigid 
compounds were usually aromatic compounds. 
CONCLUSION 
The smallest rerank score on 6-paradol means 
ithad the greatest affinity with TRPV1 as same 
as capsaicin as native ligand (shown in table 2). 
Further, 6-paradol had the potential to be used 
as a drug for treating painful diabetic 
neuropathy. 
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